All Posts by
In July 2021, the NDEWS Coordinating Center was awarded two administrative supplements from the National Institute on Drug Abuse to expand our efforts to monitor new and emerging drug trends through two new initiatives: wastewater-based epidemiology and national Poison Control data. Led by Dr. Tara Sabo-Atwood, the wastewater-based epidemiology initiative…
A new NDEWS paper, in collaboration with NPS Discovery, is now available in International Journal of Drug Policy. Led by NDEWS Co-I Dr. Elan Barenholtz and Dr. Alex Krotulski from NPS Discovery, the study evaluated the utility of using drug-related Reddit forums as an early indicator of future…
A new analysis of law enforcement drug seizures in five key regions of the United States, led by NDEWS Co-Investigator Dr. Joseph Palamar, found an increase in methamphetamine and marijuana confiscations during the COVID-19 pandemic. Investigators examined trends in seizures of marijuana, cocaine, methamphetamine, heroin, and fentanyl within five High…
NDEWS Co-Investigator Dr. Bruce Goldberger and NDEWS Scientific Advisory Group Member Dr. Barry Logan, along with other collaborators at NMS Labs and the Center for Forensic Science Research and Education, recently published an article on the synthetic cathinone eutylone (bk-EBDB), which was identified in 83 forensic investigations from thirteen states.
NDEWS Principal Investigator Dr. Linda B. Cottler, co-editor of Addictive Disorders for Current Opinion in Psychiatry, invited articles in the July 2020 issue on new psychoactive substances (NPS) and approaches to drug monitoring, including a description of the NDEWS effort from our predecessors at the University of Maryland.
NDEWS Co-Investigator Dr. Joseph Palamar discusses the re-emergence of gamma-hydroxybutyric acid (GHB) with NBC News in a new article.
Dr. Nora Volkow, the Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, describes the NDEWS COVID-19 supplement in her blog post. Read more about our initiative to track substance-use-related COVID-19 consequences through local key informant interviews in all 18 sentinel sites.
This press release from UF Health provides an overview of the new National Drug Early Warning System (NDEWS), funded to UF by the National Institute on Drug Abuse (NIDA) in April 2020.
